Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Remedica Ltd, Aharnon Str.,Limassol Industrial Estate, 3056 Limassol, Cyprus
Glitisol 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, oblong, flat, scored tablets. The tablet can be divided into equal doses. |
Each Glitisol 5 mg tablet contains 5 mg glibenclamide.
Excipients with known effect:
Each Glitisol 5 mg tablet contains 93.3 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Glibenclamide |
Glibenclamide, a second-generation, short half-life sulphonylurea, is a hypoglycaemic agent that reduces blood-glucose by stimulating insulin release by the pancreas. Sulphonylureas act on pancreatic beta-cells by inhibiting ATP-sensitive potassium channels. |
| List of Excipients |
|---|
|
Microcrystalline cellulose |
PVC/Aluminium blisters. Pack-sizes of 40, 100, and 1000 tablets.
PP containers with PE closure. Pack sizes of 1000 tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str.,Limassol Industrial Estate, 3056 – Limassol, Cyprus
19878
Date of first authorization: 13 December 2005
Date of latest renewal: 01 December 2014
| Drug | Countries | |
|---|---|---|
| GLITISOL | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
